Satellos Bioscience Inc. — Form D/A

Satellos Bioscience Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2013-11-21. The offering totals $126K, of which $126K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Richard G BarkerDirectorVancouver, A1
Noel G HallDirectorVancouver, A1
William John JaroszDirectorVancouver, A1
Peter John HnikExecutive OfficerVancouver, A1
Franklin D BergerDirectorToronto, A6
Frank GleesonDirectorToronto, A6
Frank GleesonExecutive OfficerToronto, A6
Frank GleesonPromoterToronto, A6
Michael Robert CrossExecutive OfficerToronto, A6
William McVicarDirectorToronto, A6
Brian BloomDirectorToronto, A6
Elizabeth WilliamsExecutive OfficerCroton on Hudson, NY
Stephanie D BrownDirectorToronto, A6
Michael RudnickiExecutive OfficerToronto, A6
Michael RudnickiPromoterToronto, A6
Bill JaroszDirectorToronto, A6
Adam MostafaDirectorToronto, A6
Philip D LambertExecutive OfficerToronto, A6
Courtney D WellsExecutive OfficerToronto, A6
Geoff MacKayDirectorToronto, A6
Rima Al-awarDirectorToronto, A6
Michael LiggettDirectorVancouver, A1
Michael LiggettExecutive OfficerVancouver, A1
J. Robert HallExecutive OfficerToronto, A6
Warren WhiteheadExecutive OfficerToronto, A6

Other filings by this issuer (9)

FiledFormOfferingSold
2025-01-03D$25.0M$25.0M
2023-05-25D$33.3M$33.3M
2022-09-27D$2.1M$99K
2019-09-10D$2.5M$188K
2019-03-08D$972K$152K
2014-02-05D$7.9M$2.0M
2011-11-15D$50K$50K
2009-12-01D/A$3.3M$3.3M
2009-11-06D$2.7M$2.7M

More